Table 1.
Patient characteristics in the full analytic sample and in patients who tested positive for each HCoV strain
| Analytic sample | HCoV-229E | HCoV-HKU1 | HCoV-NL63 | HCoV-OC43 | |
|---|---|---|---|---|---|
| n | 58,263 | 36 | 94 | 148 | 54 |
| Age, y, median [IQR] | 64.00 [50.00, 73.00] | 59.50 [44.50, 72.00] | 65.00 [54.25, 72.75] | 61.50 [40.50, 71.00] | 70.00 [56.25, 74.75] |
| Female (%) | 8,531 (14.6) | 4 (11.1) | 10 (10.6) | 24 (16.2) | 7 (13.0) |
| Race/ethnicity (%) | |||||
| Non-Hispanic White | 32,960 (56.6) | 23 (63.9) | 57 (60.6) | 83 (56.1) | 38 (70.4) |
| Non-Hispanic Black | 11,752 (20.2) | 4 (11.1) | 16 (17.0) | 27 (18.2) | 7 (13.0) |
| Hispanic | 5,133 (8.8) | 4 (11.1) | 10 (10.6) | 18 (12.2) | 3 (5.6) |
| Other or unknown | 8,418 (14.4) | 5 (13.9) | 11 (11.7) | 20 (13.5) | 6 (11.1) |
| Urban | 44,365 (76.1) | 30 (83.3) | 80 (85.1) | 123 (83.1) | 45 (83.3) |
| Region (%) | |||||
| Midwest | 20,012 (34.3) | 13 (36.1) | 17 (18.1) | 42 (28.4) | 8 (14.8) |
| North Atlantic | 9,145 (15.7) | 6 (16.7) | 32 (34.0) | 52 (35.1) | 13 (24.1) |
| Southeast | 12,953 (22.2) | 5 (13.9) | 15 (16.0) | 20 (13.5) | 10 (18.5) |
| Continental | 6,559 (11.3) | 2 (5.6) | 9 (9.6) | 15 (10.1) | 3 (5.6) |
| Pacific | 9,594 (16.5) | 10 (27.8) | 21 (22.3) | 19 (12.8) | 20 (37.0) |
| Frail (%) | 41,418 (71.1) | 26 (72.2) | 48 (51.1) | 99 (66.9) | 27 (50.0) |
Variable definitions are as in our prior work (7). IQR, interquartile range.